Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before June 10, 2025 to Discuss Your Rights - TMCI

Group 1 - The Gross Law Firm has issued a notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI) regarding a class action lawsuit for shareholders who purchased shares during the class period from May 8, 2023, to May 7, 2024 [1] - The allegations in the complaint include that competition negatively affected the demand for Treace Medical's primary product, the 3D bunion correction system known as "Lapiplasty," leading to a decline in revenue [1] - The company was required to accelerate plans to introduce an alternative product to osteotomy due to the decline in revenue and the misleading positive statements made by the defendants regarding the company's business and prospects [1] Group 2 - Shareholders are encouraged to register for the class action by June 10, 2025, to potentially become lead plaintiffs and participate in the case without any cost or obligation [2] - Once registered, shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2] - The Gross Law Firm aims to protect investors' rights and seeks recovery for losses incurred due to misleading statements or omissions by companies [3]